13606487 · Active · incorporated 5 years, 1 month ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Healthcare Platform Series B+
NeoVac develops proprietary lipid nanoparticle platforms for RNA technology, aiming to advance mRNA therapeutics.
Neovac is a private limited company registered at Companies House under number 13606487, incorporated on 7 September 2021, with a registered office in Abingdon. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 41 filings for this company, including 2 funding rounds. Its most recent round closed in November 2025, raising £3.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Nov 2025 | £3.5m | £54.40 |
| Round 1 | Sep 2025 | £13.3m | £210.68 |
Showing the 10 most recent of 41 filings.
See the complete cap table with every shareholder, founder tags, dilution across 5 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.